Pityriasis rosea developing after COVID-19 vaccination.
作者信息
Marcantonio-Santa Cruz O Y, Vidal-Navarro A, Pesqué D, Giménez-Arnau A M, Pujol R M, Martin-Ezquerra G
机构信息
Dermatology Department, Hospital del Mar, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Universitat Autònoma de Barcelona, Barcelona, Spain.
出版信息
J Eur Acad Dermatol Venereol. 2021 Nov;35(11):e721-e722. doi: 10.1111/jdv.17498. Epub 2021 Jul 21.
Abstract
摘要
相似文献
1
Pityriasis rosea developing after COVID-19 vaccination.
J Eur Acad Dermatol Venereol. 2021 Nov;35(11):e721-e722. doi: 10.1111/jdv.17498. Epub 2021 Jul 21.
2
Pityriasis rosea following SARS-CoV-2 vaccination: A case series.
J Cosmet Dermatol. 2021 Oct;20(10):3080-3084. doi: 10.1111/jocd.14372. Epub 2021 Aug 7.
3
Pityriasis rosea after mRNA COVID-19 vaccination.
Int J Dermatol. 2021 Sep;60(9):1150-1151. doi: 10.1111/ijd.15700. Epub 2021 Jun 10.
4
Pityriasis Rosea Associated With COVID-19 Vaccination: A Common Rash Following Administration of a Novel Vaccine.
Cutis. 2021 Dec;108(6):317-318. doi: 10.12788/cutis.0411.
5
Maculopapular eruptions following COVID-19 vaccination: Pityriasis rosea or pityriasis rosea-like eruptions?
J Cosmet Dermatol. 2023 Sep;22(9):2380-2381. doi: 10.1111/jocd.15755. Epub 2023 Jun 29.
6
Post Covid-19 vaccination papulovesicular pityriasis rosea-like eruption in a young male.
Dermatol Ther. 2021 Sep;34(5):e15040. doi: 10.1111/dth.15040. Epub 2021 Jun 28.
7
Pityriasis rosea-like eruptions following vaccination with BNT162b2 mRNA COVID-19 Vaccine.
J Eur Acad Dermatol Venereol. 2021 Sep;35(9):e546-e548. doi: 10.1111/jdv.17342. Epub 2021 May 29.
8
Pityriasis Rosea Shortly After mRNA-1273 COVID-19 Vaccination.
Int J Infect Dis. 2022 Jan;114:88-89. doi: 10.1016/j.ijid.2021.10.055. Epub 2021 Nov 2.
9
Pityriasis rosea like eruption: A dermatological manifestation of Coronavac-COVID-19 vaccine.
Dermatol Ther. 2022 Feb;35(2):e15256. doi: 10.1111/dth.15256. Epub 2021 Dec 26.
10
Pityriasis rosea following CoronaVac COVID-19 vaccination: a case report.
J Eur Acad Dermatol Venereol. 2021 Aug;35(8):e491-e493. doi: 10.1111/jdv.17316. Epub 2021 May 10.
引用本文的文献
1
A Cross-Sectional Study of Epidemiological and Clinical Aspects of Pityriasis Rosea along with Dermoscopic Analysis and Histopathology Correlation.
Indian J Dermatol. 2024 Mar-Apr;69(2):145-151. doi: 10.4103/ijd.ijd_1071_23. Epub 2024 Apr 29.
2
Pityriasis Rosea Eruption Following the Administration of Oxford-AstraZeneca Vaccine.
Cureus. 2024 Mar 17;16(3):e56310. doi: 10.7759/cureus.56310. eCollection 2024 Mar.
3
Pityriasis following COVID-19 vaccinations: a systematic review.
Dermatol Reports. 2023 Aug 9;16(1):9742. doi: 10.4081/dr.2023.9742. eCollection 2024 Mar 12.
4
Pityriasis Rosea and Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination: A Narrative Review.
Clin Cosmet Investig Dermatol. 2024 Jan 8;17:51-57. doi: 10.2147/CCID.S447834. eCollection 2024.
5
Management of coronavirus disease 2019 vaccine-induced cutaneous complications: A comprehensive literature review.
J Family Community Med. 2023 Jul-Sep;30(3):161-170. doi: 10.4103/jfcm.jfcm_3_23. Epub 2023 Jul 24.
6
The Impact of COVID-19 Vaccination on Inflammatory Skin Disorders and Other Cutaneous Diseases: A Review of the Published Literature.
Viruses. 2023 Jun 23;15(7):1423. doi: 10.3390/v15071423.
7
A Review of Pityriasis Rosea in Relation to SARS-CoV-2/COVID-19 Infection and Vaccination.
Cureus. 2023 May 9;15(5):e38772. doi: 10.7759/cureus.38772. eCollection 2023 May.
8
Manifestation of pityriasis rosea and pityriasis rosea-like eruptions after Covid-19 vaccine: A systematic review.
Immun Inflamm Dis. 2023 Apr;11(4):e804. doi: 10.1002/iid3.804.
9
Pityriasis rosea and pityriasis rosea-like eruption after anti-SARS-CoV-2 vaccination: a report of five cases and review of the literature.
Dermatol Reports. 2022 Jul 6;15(1):9503. doi: 10.4081/dr.2022.9503. eCollection 2023 Mar 7.
10
Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature.
Clin Cosmet Investig Dermatol. 2022 Nov 6;15:2369-2382. doi: 10.2147/CCID.S388245. eCollection 2022.
本文引用的文献
1
Pityriasis rosea in otherwise asymptomatic confirmed COVID-19-positive patients: A report of 2 cases.
JAAD Case Rep. 2021 Jan;7:93-94. doi: 10.1016/j.jdcr.2020.10.035. Epub 2020 Nov 7.
2
Pityriasis rosea as a cutaneous manifestation of COVID-19 infection.
J Eur Acad Dermatol Venereol. 2020 Sep;34(9):e436-e437. doi: 10.1111/jdv.16579. Epub 2020 Jun 11.
3
Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases.
Br J Dermatol. 2020 Jul;183(1):71-77. doi: 10.1111/bjd.19163. Epub 2020 Jun 10.
4
Pityriasis rosea and pityriasis rosea-like eruptions: How to distinguish them?
JAAD Case Rep. 2018 Sep 14;4(8):800-801. doi: 10.1016/j.jdcr.2018.04.002. eCollection 2018 Sep.
5
Vaccine-induced pityriasis rosea and pityriasis rosea-like eruptions: a review of the literature.
J Eur Acad Dermatol Venereol. 2016 Mar;30(3):544-5. doi: 10.1111/jdv.12942. Epub 2014 Dec 29.
6
Pityriasis rosea--an update.
Indian J Dermatol Venereol Leprol. 2005 Sep-Oct;71(5):311-5. doi: 10.4103/0378-6323.16779.
7
Pityriasis rosea. A statistical, clinical, and laboratory investigation of 826 patients and matched healthy controls.
Acta Derm Venereol Suppl (Stockh). 1962;42(Suppl 50):1-68. doi: 10.2340/0001555542168.
Zotero 插件